Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2011-5-5
pubmed:abstractText
Gypenosides (Gyp), found in Gynostemma pentaphyllum Makino, has been used as a folk medicine in the Chinese population for centuries and is known to have diverse pharmacologic effects, including anti-proliferative and anti-cancer actions. However, the effects of Gyp on prevention from invasion and migration of oral cancer cells are still unsatisfactory. The purpose of this study was to investigate effects of Gyp treatment on migration and invasion of SAS human oral cancer cells. SAS cells were cultured in the presence of 90 and 180 ?g/mL Gyp for 24 and 48 hours. Gyp induced cytotoxic effects and inhibited SAS cells migration and invasion in dose- and time-dependent response. Wound-healing assay and boyden chamber assay were carried out to investigate Gyp-inhibited migration and invasion of SAS cells. Gyp decreased the abundance of several proteins, including nuclear factor-kappa B (NF-?B), cyclooxygenase-2 (COX-2), extracellular signal-regulated kinase 1/2 (ERK1/ 2), matrix metalloproteinase-9, -2 (MMP-9, -2), sevenless homolog (SOS), Ras, urokinase-type plasminogen activator (uPA), focal adhesion kinase (FAK) and RAC-alpha serine/threonine-protein kinase (Akt), in a time-dependent manner. In addition, Gyp decreased mRNA levels of MMP-2, MMP-7, MMP-9 but did not affect FAK and Rho A mRNA levels in SAS cells. These results provide evidences for the role of Gyp as a potent anti-metastatic agent, which can markedly inhibit the metastatic and invasive capacity of oral cancer cells. The inhibition of NF-?B and MMP-2, -7 and -9 signaling may be one of the mechanisms that is present in Gyp-inhibited cancer cell invasion and migration.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Phytogenic, http://linkedlifedata.com/resource/pubmed/chemical/Extracellular Signal-Regulated MAP..., http://linkedlifedata.com/resource/pubmed/chemical/MAPK1 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/MMP2 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 2, http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 9, http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinases, http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinase 1, http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinase 3, http://linkedlifedata.com/resource/pubmed/chemical/NF-kappa B, http://linkedlifedata.com/resource/pubmed/chemical/Plant Extracts, http://linkedlifedata.com/resource/pubmed/chemical/Urokinase-Type Plasminogen Activator, http://linkedlifedata.com/resource/pubmed/chemical/gypenoside
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1477-0903
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
30
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
406-15
pubmed:meshHeading
pubmed-meshheading:20511288-Antineoplastic Agents, Phytogenic, pubmed-meshheading:20511288-Cell Line, Tumor, pubmed-meshheading:20511288-Cell Movement, pubmed-meshheading:20511288-Cell Survival, pubmed-meshheading:20511288-Dose-Response Relationship, Drug, pubmed-meshheading:20511288-Extracellular Signal-Regulated MAP Kinases, pubmed-meshheading:20511288-Gynostemma, pubmed-meshheading:20511288-Humans, pubmed-meshheading:20511288-Matrix Metalloproteinase 2, pubmed-meshheading:20511288-Matrix Metalloproteinase 9, pubmed-meshheading:20511288-Matrix Metalloproteinases, pubmed-meshheading:20511288-Mitogen-Activated Protein Kinase 1, pubmed-meshheading:20511288-Mitogen-Activated Protein Kinase 3, pubmed-meshheading:20511288-Mouth Neoplasms, pubmed-meshheading:20511288-NF-kappa B, pubmed-meshheading:20511288-Neoplasm Invasiveness, pubmed-meshheading:20511288-Plant Extracts, pubmed-meshheading:20511288-Signal Transduction, pubmed-meshheading:20511288-Time Factors, pubmed-meshheading:20511288-Urokinase-Type Plasminogen Activator
pubmed:year
2011
pubmed:articleTitle
Gypenosides inhibits migration and invasion of human oral cancer SAS cells through the inhibition of matrix metalloproteinase-2 -9 and urokinase-plasminogen by ERK1/2 and NF-kappa B signaling pathways.
pubmed:affiliation
School of Chinese Medicine, China Medical University, Taichung, Taiwan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't